Utah Medical Products EBITDA Margin 2010-2025 | UTMD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Utah Medical Products (UTMD) over the last 10 years. The current EBITDA margin for Utah Medical Products as of March 31, 2025 is .
Utah Medical Products EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.04B $0.02B 41.03%
2024-12-31 $0.04B $0.02B 42.50%
2024-09-30 $0.04B $0.02B 41.86%
2024-06-30 $0.05B $0.02B 43.48%
2024-03-31 $0.05B $0.02B 44.90%
2023-12-31 $0.05B $0.02B 45.10%
2023-09-30 $0.05B $0.03B 47.17%
2023-06-30 $0.05B $0.03B 49.06%
2023-03-31 $0.05B $0.03B 50.94%
2022-12-31 $0.05B $0.03B 51.92%
2022-09-30 $0.05B $0.03B 52.94%
2022-06-30 $0.05B $0.03B 52.94%
2022-03-31 $0.05B $0.03B 52.94%
2021-12-31 $0.05B $0.03B 54.00%
2021-09-30 $0.05B $0.03B 53.06%
2021-06-30 $0.05B $0.02B 52.17%
2021-03-31 $0.04B $0.02B 50.00%
2020-12-31 $0.04B $0.02B 50.00%
2020-09-30 $0.04B $0.02B 50.00%
2020-06-30 $0.04B $0.02B 50.00%
2020-03-31 $0.05B $0.02B 51.06%
2019-12-31 $0.05B $0.02B 51.06%
2019-09-30 $0.05B $0.02B 51.11%
2019-06-30 $0.04B $0.02B 51.16%
2019-03-31 $0.04B $0.02B 52.38%
2018-12-31 $0.04B $0.02B 52.38%
2018-09-30 $0.04B $0.02B 52.38%
2018-06-30 $0.04B $0.02B 52.38%
2018-03-31 $0.04B $0.02B 52.38%
2017-12-31 $0.04B $0.02B 51.22%
2017-09-30 $0.04B $0.02B 50.00%
2017-06-30 $0.04B $0.02B 50.00%
2017-03-31 $0.04B $0.02B 48.72%
2016-12-31 $0.04B $0.02B 48.72%
2016-09-30 $0.04B $0.02B 50.00%
2016-06-30 $0.04B $0.02B 50.00%
2016-03-31 $0.04B $0.02B 50.00%
2015-12-31 $0.04B $0.02B 50.00%
2015-09-30 $0.04B $0.02B 50.00%
2015-06-30 $0.04B $0.02B 48.78%
2015-03-31 $0.04B $0.02B 48.78%
2014-12-31 $0.04B $0.02B 48.78%
2014-09-30 $0.04B $0.02B 46.34%
2014-06-30 $0.04B $0.02B 45.00%
2014-03-31 $0.04B $0.02B 45.00%
2013-12-31 $0.04B $0.02B 45.00%
2013-09-30 $0.04B $0.02B 45.00%
2013-06-30 $0.04B $0.02B 47.50%
2013-03-31 $0.04B $0.02B 45.00%
2012-12-31 $0.04B $0.02B 43.90%
2012-09-30 $0.04B $0.02B 43.90%
2012-06-30 $0.04B $0.02B 40.48%
2012-03-31 $0.04B $0.02B 40.48%
2011-12-31 $0.04B $0.01B 36.84%
2011-09-30 $0.03B $0.01B 35.29%
2011-06-30 $0.03B $0.01B 34.48%
2011-03-31 $0.03B $0.01B 32.00%
2010-12-31 $0.02B $0.01B 33.33%
2010-09-30 $0.02B $0.01B 37.50%
2010-06-30 $0.03B $0.01B 40.00%
2010-03-31 $0.03B $0.01B 40.00%
2009-12-31 $0.03B $0.01B 44.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.178B $0.041B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.390B 27.94
Boston Scientific (BSX) United States $154.114B 38.58
Stryker (SYK) United States $145.370B 30.40
EssilorLuxottica (ESLOY) France $128.999B 0.00
Medtronic (MDT) Ireland $107.400B 15.23
Haleon (HLN) United Kingdom $51.375B 29.26
Lonza Group Ag (LZAGY) Switzerland $50.537B 0.00
ResMed (RMD) United States $35.781B 26.88
GE HealthCare Technologies (GEHC) United States $32.121B 15.25
Agilent Technologies (A) United States $31.661B 20.57
Terumo (TRUMY) Japan $27.316B 35.48
Insulet (PODD) United States $22.872B 89.78
Koninklijke Philips (PHG) Netherlands $21.440B 15.41
Zimmer Biomet Holdings (ZBH) United States $18.026B 11.58
Baxter (BAX) United States $15.164B 11.32
Smith & Nephew SNATS (SNN) United Kingdom $12.767B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $5.893B 20.51
Lantheus Holdings (LNTH) United States $5.336B 13.46
Prestige Consumer Healthcare (PBH) United States $4.224B 18.87
Perrigo (PRGO) Ireland $3.672B 9.31
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.304B 15.05
ICU Medical (ICUI) United States $3.213B 23.69
Envista Holdings (NVST) United States $3.068B 25.49
GN Store Nord (GNNDY) Denmark $2.170B 17.98
QuidelOrtho (QDEL) United States $2.005B 13.79
LeMaitre Vascular (LMAT) United States $1.817B 40.61
AtriCure (ATRC) United States $1.683B 0.00
Acuren (TIC) United States $1.297B 0.00
Neogen (NEOG) United States $1.235B 15.81
AdaptHealth (AHCO) United States $1.181B 11.99
Green Thumb Industries (GTBIF) United States $1.143B 25.71
Kestra Medical Technologies (KMTS) United States $1.062B 0.00
Phibro Animal Health (PAHC) United States $0.996B 12.74
BioLife Solutions (BLFS) United States $0.983B 0.00
InMode (INMD) Israel $0.907B 9.14
Evolus (EOLS) United States $0.643B 0.00
CeriBell (CBLL) United States $0.621B 0.00
Curaleaf Holdings (CURLF) Canada $0.549B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.542B 0.00
Valneva SE (VALN) France $0.536B 0.00
Owens & Minor (OMI) United States $0.491B 4.07
Capricor Therapeutics (CAPR) United States $0.466B 0.00
Surmodics (SRDX) United States $0.421B 0.00
Tilray Brands (TLRY) Canada $0.410B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.334B 0.00
VAREX IMAGING (VREX) United States $0.316B 11.61
Aurora Cannabis (ACB) Canada $0.293B 52.10
Cresco Labs (CRLBF) United States $0.289B 0.00
Viemed Healthcare (VMD) United States $0.259B 21.87
Sanara MedTech (SMTI) United States $0.259B 0.00
Cerus (CERS) United States $0.252B 0.00
ZimVie (ZIMV) United States $0.251B 11.40
Verano Holdings (VRNOF) United States $0.226B 0.00
Sanuwave Health (SNWV) United States $0.224B 0.00
Canopy Growth (CGC) Canada $0.222B 0.00
OraSure Technologies (OSUR) United States $0.213B 0.00
Quanterix (QTRX) United States $0.204B 0.00
TriSalus Life Sciences (TLSI) United States $0.197B 0.00
Biote (BTMD) United States $0.194B 5.45
Brainsway (BWAY) Israel $0.193B 51.10
High Tide (HITI) Canada $0.186B 0.00
Omeros (OMER) United States $0.180B 0.00
Organigram Global (OGI) Canada $0.175B 0.00
Exagen (XGN) United States $0.152B 0.00
FitLife Brands (FTLF) United States $0.139B 17.12
Jin Medical (ZJYL) China $0.125B 0.00
TerrAscend (TSNDF) Canada $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Fonar (FONR) United States $0.090B 11.60
MacroGenics (MGNX) United States $0.088B 0.00
Veru (VERU) United States $0.085B 0.00
Agape ATP (ATPC) $0.080B 0.00
Quipt Home Medical (QIPT) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.061B 0.00
Zynex (ZYXI) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
United Health Products (UEEC) United States $0.051B 0.00
Modular Medical (MODD) United States $0.043B 0.00
United-Guardian (UG) United States $0.038B 13.29
Rockwell Medical (RMTI) United States $0.034B 0.00
Nephros (NEPH) United States $0.033B 44.71
Allurion Technologies (ALUR) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.008B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00